Prestige Consumer Healthcare PBH Cash Flow Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| $190.3M+2.0% | $186.5M-7.1% | $200.84M-5.7% | $213M-0.7% | $214.61M+0.3% | ||
| $31.27M+3.6% | $30.17M+2.5% | $29.45M-0.9% | $29.72M-1.5% | $30.17M-1.9% | ||
| $10.84M-0.8% | $10.92M-1.1% | $11.05M-3.2% | $11.41M+2.3% | $11.16M-8.2% | ||
| $257.63M-6.9% | $276.63M+5.0% | $263.44M-4.5% | $275.75M+9.6% | $251.52M-2.0% | ||
| $11.18M+18.3% | $9.45M+18.3% | $7.99M+0.9% | $7.91M-3.8% | $8.22M+4.3% | ||
| $123.74M+30.4% | $94.86M+43.7% | $65.99M+77.8% | $37.12M+350% | $8.25M-6.5% | ||
| -$136.84M0.0% | -$136.91M-654% | -$18.16M-5.2% | -$17.26M+1.1% | -$17.45M+39.8% | ||
| $156.28M-6.4% | $166.91M+35.2% | $123.49M+105% | $60.31M+17.1% | $51.51M— | ||
| $40M+33.3% | $30M— | —— | —— | —— | ||
| $40M+130% | -$135M-80.0% | -$75M-114% | -$35M— | $0+100% | ||
| -$156.06M-20.6% | -$129.45M+26.7% | -$176.58M-15.5% | -$152.84M+16.1% | -$182.08M+23.8% | ||
| —— | —— | —— | $105.91M+103% | $52.08M+531% | ||
| $246.45M-7.8% | $267.19M+4.6% | $255.45M-4.6% | $267.84M+10.1% | $243.29M-2.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Prestige Consumer Healthcare's cash flow data come from?
- Every line is extracted from Prestige Consumer Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.